Thank you, Garrett. Good morning and thank you for joining us today. Our third quarter results are a testament to the revamped portfolio strategy the team has been executing on throughout the year. On the asset side, fair value across the portfolio slightly increased in the quarter, which we believe drove better than many of our peers. Our strategy to diversify the portfolio and when rates were low with spreads type, to position ourselves in a higher coupon short duration fixed-rate securities benefited GECC as it enabled us to better withstand the rapid rise in interest rates. In the third quarter, we advantageously deployed approximately $40 million into new investments at average yields in excess of 12%, with 60% of those deployments in floating rate investments. Approximately $30 million of assets were monetized in the quarter had average yields below 10%, with 90% of those assets comprised of fixed rate investments. As a result, nearly half of our debt investment portfolio at quarter end consisted of floating rate debt, up from one-third just one quarter ago. Average yield on our credit portfolio also increased to 11.6% from 10.3% at June 30. Going forward, you should expect us to focus more time and capital on investments to benefit from rising rates as opposed to fixed rate investments. At the same time, NII of $1.1 million or $0.14 per share was below our expectations largely due to costs and expenses related to certain legacy investments and the formation of Great Elm Healthcare Finance, which collectively impacted NII by approximately $0.09. In addition, we estimate NII was impacted by approximately $0.03 from the continued cash drag, resulting from our measured deployment of capital noted on our prior call. Lastly, our specialty finance platforms did not perform as anticipated, given a low in originations over the summer and some temporary disruption from management changes. We expect the elevated expenses to abate in the fourth quarter and along with an increase in deployments should result in a corresponding increase in NII. As I alluded to earlier, Great Elm is adding to its specialty finance business by launching a healthcare finance platform that provides capital solutions to healthcare businesses across the country. In the quarter, we identified a senior management team led by industry veteran, Mike Gervais, to lead the specialized secured lending vertical with support from our existing ABL platform, Sterling Commercial Credit. Mike has built two healthcare lending platforms over the past two decades and I am extremely excited to welcome him into the Great Elm family. We are in the process of identifying assets and potential finance partners as well as building out the operations for the health care initiative, supported by our experienced team at Sterling. We remain measured with respect to deploying capital in the current market environment and are very focused on finding investments with limited risk of permanent capital impairment and durable returns. In the near term, our goal is to grow our portfolio and our investment income to cover our quarterly distribution on a regular basis and we believe you will begin to see progress toward that NII goal in the fourth quarter. As we continue to navigate through the current environment, we remain excited for our future prospects and the opportunity set the market volatility has started to provide in both the secondary credit and the private ABL markets. I remain very confident in this team, and we are making steady progress building on the foundation we put in place. With that, I’d like to hand the call over to Keri to discuss our third quarter 2022 performance.